Leucid Bio Appoints Filippo Petti as Chief Executive Officer
/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a biotech company pursuing a differentiated approach to develop next generation Chimeric Antigen...
Stay updated with breaking news from Filippo Petti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a biotech company pursuing a differentiated approach to develop next generation Chimeric Antigen...
Listed limited liability company Rue Edouard Belin, 2 1435 Mont-Saint-Guibert LER Nivelles 0891.118.115 ... | April 4, 2023
Regulatory News: Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD): Dear Shareholder, 2022 has been a crossroad year for Celyad Oncology (the "Company"), with important changes and
01.03.2023 - Regulatory News: Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD): Dear Shareholder, 2022 has been a crossroad year for Celyad Oncology (the “Company”), with important changes and turning points. Whilst our clinical programs had clear ... Seite 1
MONT-SAINT-GUIBERT, Belgium, Feb. 28, 2023 -- The following is a statement by Celyad Oncology: Dear Shareholder, 2022 has been a crossroad year for Celyad Oncology , with important changes... | February 28, 2023